The influence of Sr doses on the in vitro biocompatibility and in vivo degradability of single-phase Sr-incorporated HAP cement

Journal of Biomedical Materials Research - Part A

Volumn 86, Issue 4, 2008, Pages 947-958

  Dagang, Guo ^a   Xu, Kewei ^a   Han, Yong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Biocompatibility; Degradability; Sr incorporated hydroxyapatite cement

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; CALCIUM; CEMENT MANUFACTURE; CEMENTS; CHEMOTHERAPY; DEGRADATION; HYDROXYAPATITE; IMAGING TECHNIQUES; MINERALOGY; PHASE INTERFACES; PHOTODEGRADATION; PHOTOGRAPHY; RATE CONSTANTS; SPECTRUM ANALYZERS; SULFATE MINERALS;

ACUTE TOXICITIES; CYTOXICITY; DEGRADABILITY; DEGRADATION RATES; ENERGY DISPERSIONS; GRADIENT DISTRIBUTIONS; HEMOLYTIC REACTION; HYDROXYAPATITE CEMENT; IN VITRO BIOCOMPATIBILITY; IN-VITRO; IN-VIVO; MOLAR RATIOS; OPTICAL TRANSMISSIONS; PHYSIO-CHEMICAL PROPERTIES; SR-INCORPORATED HYDROXYAPATITE CEMENT; X-RAY SPECTRUM ANALYSIS;

STRONTIUM;

BONE CEMENT; CALCIUM; HYDROXYAPATITE; PYROGEN; STRONTIUM;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOLOGICAL ACTIVITY; BONE; BONE MINERALIZATION; CONTROLLED STUDY; CYTOTOXICITY; EXPERIMENTAL RABBIT; FEMALE; FEMUR; HEMOLYSIS; IMPLANT; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MUSCLE; NONHUMAN; PHOTOGRAPHY; PHYSICAL CHEMISTRY; RAT;

ACUTE TOXICITY TESTS; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL DEATH; CELL PROLIFERATION; FEMALE; FEMUR; HEMOLYSIS; HYDROXYAPATITES; MALE; MATERIALS TESTING; MUSCLES; PROSTHESIS IMPLANTATION; PYROGENS; RABBITS; RATS; STRONTIUM; TIME FACTORS; WEIGHT LOSS;

EID: 50149103544     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31687     Document Type: Article

References (40)

1. Brown WE, Chow LC. A new calcium phosphate cement, water-setting cement. In: Brown PW, editor. Cements Research Progress. Westervillie, OH: American Ceramic Society; 1986. p 352-379.
2. Brown WE, Chow LC. Combinations of sparingly soluble calcium phosphates in slurried and paste as mineralizers and cements. US Pat. 4,612,053 (1986).
3. Constantz BR, Barr BM, Ison IC, Fulmer MT. Histological, chemical and crystallographic analysis of four calcium phosphate cements in different rabbit osseous sites. J Biomed Mater Res 1998;43:451-461.
4. Friedman CD, Constantino PD, Jones K. Hydroxyapatite cement. II. Obliteration and reconstruction of the catfrontal sinus. Arch Otolaryngol Head Neck Surg 1991;117:385-389.
5. Constantino PD, Friedman CD, Jones R. Experimental hydroxyapatite cement cranioplasty. Plast Reconstr Surg 1992;90:174-178.
6. Wang HB, Lee JK, Moursi A, Lannutti JJ. Ca/P ratio effects on the degradation of hydroxyapatite in vitro. J Biomed Mater Res 2003;67:599-608.
7. Monma H, Kanazawa T. The hydration of α-tricalcium phosphate. Yogyo-Kyokai-shi 1976;84:209-213.
8. Quanzu Y, Tom T, Dean-Mo L. Influence of apatite seeds on the synthesis of calcium phosphate cement. Biomaterials 2002;23:2751-2760.
9. White E, Shors EC. Biomaterial aspects of Interpore-200 porous hydroxyapatite. Dent Clin North Am 1986;30:49-67.
10. Dietmar WH. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000;21:2529-2543.
11. Xu HHK, Eichmiller FC, Giuseppetti AA. Reinforcement of a self-setting calcium phosphate cement with different fibers. J Biomed Mater Res 1999;52:107-114.
12. Holmes RE, Bucholz RW, Monney V. Porous hydroxyapatite as a bone-graft substitute in metaphyseal defects. J Bone Joint Surg 1986;68:904-911.
13. Chang BS, Lee CK, Hong KS, Youn HJ, Ryu HS, Chung SS, Park KW. Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials 2000;21:1291-1298.
14. Simske SJ, Ayers RA, Bateman TA. Porous materials for bone engineering. In: Liu DM, Dixit V, editors. Materials Science Forum, Vol. 250: Porous Materials for Tissue Engineering. Enfield, NH: Transtech; 1997. p 151-182.
15. Takagi S, Chow LC. Formation of macropores in calcium phosphate cement implants. J Mater Sci Mater Med 2001;12:135-139.
16. Le Huec JC, Schaeverbeke T, Clement D, Faber J, Le Rebeller A. Influence of porosity on the mechanical resistance of hydroxyapatite ceramics under compressive stress. Biomaterials 1995;16:113-118.
17. Baig AA, Fox JL, Hsu J, Wang ZR, Otsuka M, Higuchil WI, Legeros RZ. Effect of carbonate content and crystallinity on the metastable equilibrium solubility behavior of carbonated apatites. J Colloid Interface Sci 1996;179:608-617.
18. Tang RK, Henneman ZJ, Nancollas GH. Constant composition kinetics study of carbonated apatite dissolution. J Cryst Growth 2003;249:614-624.
19. Shellis RP, Lee AR, Wilson RM. Observations on the apparent solubility of carbonate-apatite. J Colloid Interface Sci 1999;218:351-358.
20. Alexandra EP, Claudia MB, Maria AL, Jose DS, Serena MB, William B. Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon-substituted hydroxyapatite in vitro and in vivo. J Biomed Mater Res 2004;69A:670-679.
21. Yamamoto H, Niwa S, Hori M, Hattori T, Sawai K, Aoki S, Hirano M, Takeuchi H. Mechanical strength of calcium phosphate cement in vivo and in vitro. Biomaterials 1998;19:1587-1591.
22. Bermudez O, Boltong MG, Driessens FCM, Plannell JA. Compressive strength and diametral tensile strength of some calcium-orthophosphate cements: A pilot study. J Mater Sci Mater Med 1993;4:389-393.
23. Driessens FCM, Boltong MG, Bermudez O, Ginebra MP, Fernandez E, Planell JA. Effective formulations for the preparation of calcium phosphate bone cements. J Mater Sci Mater Med 1994;5:164-170.
24. Christoffersen J, Christoffersen MR, Kolthoff N. Effects of strontium ions on growth and dissolution of hydroxtapatite and on bone mineral detection. Bone 1997;20:47-52.
25. Shorr E, Carter AC. The usefulness of strontium as an adjuvant to calcium in the remineralization of the skeleton in man. Bull Hosp Joint Dis 1952;13:59-66.
26. Chen DM, Fu YF. Evaluation on the mechanical properties of the solid solution of strontium-substituted hydroxyapatite. Chin J Stoma Mater Appar 2001;19:178-183.
27. Roberts JT, Russell M, Kirk D, Van Rijn P, Vandevivere J. Strontium 89 in early relapse of hormone treated metastatic prostate cancer: Can it delay onset of bone pain? Proceedings of the 44th Annual ASTRO Meeting, 2002. p 193.
28. Grynpa MD, Hamilton E, Cheung R. Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone 1996;18:253-258.
29. Guo DG, Xu KW, Zhao XY, Han Y. Development of a strontium-containing hydroxyapatite bone cement. Biomaterials 2005;26:4073-4083.
30. Zhao F, Lu WW, Luk KDK, Cheung KMC, Wong CT, Leong JCY, Yao KD. Surface treatment of injectable strontium-containing bioactive bone cement for vertebroplasy. J Biomed Mater Res 2004;69B:79-86.
31. Li YW, Leong JCY, Lu WW, Luk KDK, Cheung KMC, Chiu KY, Chow SP. A novel injectable bioactive bone cement for spinal surgery: A developmental and preclinical study. J Biomed Mater Res 2004;52:164-170.
32. Wong CT, Chen QZ, Lu WW, Leong JCY, Chan WK, Cheung KMC, Luk KDK. Ultrastructure study of mineralization of a strontium-containing hydroxyapatite (Sr-HA) cement in vivo. J Biomed Mater Res 2004;70A:428-435.
33. Rokita E, Mutsaers PHA, Quaedackers JA, Taton G, de Voigt MJA. Bone mineralization after strontium and fluoride treatment in osteoporosis. Nucl Instr Meth B 1999;158:412-417.
34. Tang PF. Study on the Porous Carbonized Hydroxyapatite Bone Cement. Beijing: CPLA Medical Academy; 2002.
35. Chinese National Standard for Medical Devices and Implants. GB/T 16175-1996; 2003. p 6-8.
36. Ivanov VN. Effect of toxic doses of strontium on redox processes. Toxicol Lett (Suppl) 1995;78:43.
37. Dahl SG, Allain P, Marie PL, Mauras Y, Boivin G, Ammann P, Tsouderos Y, Delmas PD, Christiansen C. Incorporation and distribution of strontium in bone. Bone 2001;28:446-453.
38. Blake GM Zivanovic MA, McEwan AJ, Ackery DM. Sr-89 therapy: Strontium kinetics in metastatic bone disease. J Nucl Med 1986;27:1030-1035.
39. Blake GM, Zivanovic MA, McEwan AJ, Ackery DM. Sr-89 therapy: Sr-89 strontium kinetics in disseminated carcinoma of the prostate. Eur J Nucl Med 1986;12:447-454.
40. Wong CT, Lu WW, Chan WK, Cheung KMC, Luk KDK, Lu DS, Rabie ABM, Deng LF, Leong JCY. In vivo cancellous bone remodeling on a strontium-containing hydroxyapatite (Sr-HA) bioactive cement. J Biomed Mater Res 2004;68A:513-521.